Listen: Exploring Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights

May 14, 2021

President Joe Biden has thrown his support to an international effort to waive drugmakers’ patent rights on the covid vaccines, but the pharmaceutical industry vows to fight back. Julie Rovner, KHN’s chief Washington correspondent, joins The Atlantic’s “Social Distance” podcast, hosted by Dr. James Hamblin and Maeve Higgins, to talk about the current patent controversy and how the drug industry has protected itself over the years with vibrant campaigns about the needs for high profits to support drug development.

X
Facebook
LinkedIn
Email
Print
Republish This Story

Copy And Paste To Republish This Story

Listen: Exploring Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights

May 14, 2021

Article HTML

<h1>Listen: Exploring Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights</h1>

<p>President Joe Biden has thrown his support to an international effort to waive drugmakers’ patent rights on the covid vaccines, but the pharmaceutical industry vows to fight back. Julie Rovner, KHN’s chief Washington correspondent, joins The Atlantic’s “Social Distance” podcast, hosted by Dr. James Hamblin and Maeve Higgins, to talk about the current patent controversy and how the drug industry has protected itself over the years with vibrant campaigns about the needs for high profits to support drug development.</p>
<div class="sharedaddy sd-sharing-enabled"><div class="robots-nocontent sd-block sd-social sd-social-text sd-sharing"><div class="sd-content"><ul><li class="share-x"><a rel="nofollow noopener noreferrer" data-shared="sharing-x-1309358" class="share-x sd-button no-icon" href="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/?share=x" target="_blank" title="Click to share on X" ><span>X</span></a></li><li class="share-facebook"><a rel="nofollow noopener noreferrer" data-shared="sharing-facebook-1309358" class="share-facebook sd-button no-icon" href="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/?share=facebook" target="_blank" title="Click to share on Facebook" ><span>Facebook</span></a></li><li class="share-linkedin"><a rel="nofollow noopener noreferrer" data-shared="sharing-linkedin-1309358" class="share-linkedin sd-button no-icon" href="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/?share=linkedin" target="_blank" title="Click to share on LinkedIn" ><span>LinkedIn</span></a></li><li class="share-email"><a rel="nofollow noopener noreferrer" data-shared="" class="share-email sd-button no-icon" href="mailto:?subject=%5BShared%20Post%5D%20Listen%3A%20Exploring%20Controversial%20Efforts%20to%20Waive%20Drugmakers%E2%80%99%20Vaccine%20Patent%20Rights&body=https%3A%2F%2Fkffhealthnews.org%2FMTMwOTM1OA&share=email" target="_blank" title="Click to email a link to a friend" data-email-share-error-title="Do you have email set up?" data-email-share-error-text="If you're having problems sharing via email, you might not have email set up for your browser. You may need to create a new email yourself." data-email-share-nonce="9f9be47b5b" data-email-share-track-url="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/?share=email"><span>Email</span></a></li><li class="share-print"><a rel="nofollow noopener noreferrer" data-shared="" class="share-print sd-button no-icon" href="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/#print" target="_blank" title="Click to print" ><span>Print</span></a></li><li class="share-republish">
				<a
					rel="nofollow"
					class="share-republish sd-button"
					title="Republish this story"
					href="https://kffhealthnews.org/news/article/listen-pandemics-patents-and-profits/view/republish/" >
					<span>Republish This Story</span>
				</a>
			</li></ul></div></div></div>

We encourage organizations to republish our content, free of charge. Here’s what we ask:

You must credit us as the original publisher, with a hyperlink to our kffhealthnews.org site. If possible, please include the original author(s) and KFF Health News” in the byline. Please preserve the hyperlinks in the story.

Have questions? Let us know at KHNHelp@kff.org